Form 4: DENTSPLY SIRONA Executive Boosts Equity Holdings
Insider Transaction Report
DENTSPLY SIRONA's SVP, CHRO, Andrea L. Frohning, increased her beneficial ownership of common stock and phantom stock through dividend reinvestments.
Summary
- Andrea L. Frohning, Senior Vice President and Chief Human Resources Officer (SVP, CHRO) of DENTSPLY SIRONA Inc. (XRAY), acquired additional equity in the company.
- On January 9, 2026, Frohning acquired 392.387 shares of Common Stock at a price of $0.
- These Common Stock shares represent dividends on restricted stock units (RSUs) and are subject to the same vesting terms as the underlying awards, vesting simultaneously with the related RSUs.
- On the same date, Frohning acquired 22.7283 shares of Phantom Stock under the Supplemental Executive Retirement Plan (SERP) at a price of $12.22 per share.
- The Phantom Stock represents accrued dividends and is the economic equivalent of one share of common stock, becoming payable in common stock upon the reporting person's termination of employment.
- Following these transactions, Frohning beneficially owns 34,002.252 shares of Common Stock and 1,759.2738 shares of Phantom Stock.
Sentiment
Score: 7
Explanation: The filing indicates an increase in beneficial ownership by a key executive through dividend reinvestment, which generally signals continued alignment of management interests with shareholder value. This is a routine, positive, but not highly impactful event.
Positives
- Increased beneficial ownership by a key executive, Andrea L. Frohning, which aligns her interests more closely with those of shareholders.
- The acquisition of shares through dividends indicates a reinvestment of earnings back into the company's equity by management.
Industry Context
This transaction reflects standard executive compensation practices, where equity awards and their associated dividends are used to align management interests with long-term shareholder value. It does not provide specific insights into broader industry trends for dental products and technologies.
Related Party Transactions
- The acquisition of common stock and phantom stock by Andrea L. Frohning, SVP, CHRO, through dividend reinvestment is a routine related-party transaction within the scope of executive compensation.
Stakeholder Impact
- Shareholders: Increased alignment of executive interests with shareholder value through greater equity ownership.
- Employees: No direct impact on general employees.
Key Dates
| Date | Description |
|---|---|
| 01/09/2026 | Date of transactions for both Common Stock and Phantom Stock acquisitions. |
| 01/13/2026 | Date the Form 4 was signed by the attorney-in-fact for Andrea Frohning. |
Recommendation
holdThis Form 4 details a routine acquisition of additional equity by a senior executive through dividend reinvestment. While it indicates continued alignment of management's interests with shareholders, it does not represent a significant new investment or a change in the company's fundamental outlook that would warrant a change in investment recommendation. Therefore, a 'hold' recommendation is appropriate, maintaining current positions based on broader company fundamentals.
Keywords
DENTSPLY SIRONA, XRAY, Form 4, Insider Transaction, Beneficial Ownership, Common Stock, Phantom Stock, RSU, Dividend Reinvestment, Executive Compensation
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.